Leerink Partners Maintains Outperform on Incyte, Raises Price Target to $155
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Leerink Partners analyst Andrew Berens maintains Incyte (NASDAQ:INCY) with a Outperform and raises the price target from $131 to $155.
Leerink Partners analyst Andrew Berens maintains Incyte (NASDAQ:INCY) with a Outperform and raises the price target from $131 to $155.